Susquehanna International Group, LLP Sage Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$7.02 - $13.08 $424,710 - $791,340	60,500 Added 59.78%	161,700 $1.17 Million
Q2 2024 Aug 15, 2024	BUY	$10.58 - $17.9 $422,142 - $714,210	39,900 Added 65.09%	101,200 $1.1 Million
Q1 2024 May 07, 2024	SELL	$18.62 - $26.95 $1.78 Million - $2.58 Million	-95,800 Reduced 60.98%	61,300 $1.15 Million
Q4 2023 Feb 14, 2024	SELL	$17.1 - $22.26 $3.07 Million - $4 Million	-179,600 Reduced 53.34%	157,100 $3.4 Million
Q3 2023 Nov 14, 2023	BUY	$16.75 - $48.98 $3.01 Million - $8.8 Million	179,700 Added 114.46%	336,700 $6.93 Million
Q2 2023 Aug 11, 2023	SELL	$40.65 - $59.54 $1.48 Million - $2.16 Million	-36,300 Reduced 18.78%	157,000 $7.38 Million
Q1 2023 May 16, 2023	BUY	$37.27 - $46.57 $3.07 Million - $3.84 Million	82,500 Added 74.46%	193,300 $8.11 Million
Q4 2022 Feb 14, 2023	SELL	$32.2 - $43.61 $1.27 Million - $1.71 Million	-39,300 Reduced 26.18%	110,800 $4.23 Million
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $1.51 Million - $2.03 Million	46,800 Added 45.3%	150,100 $5.88 Million
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $1.38 Million - $1.91 Million	50,200 Added 94.54%	103,300 $3.34 Million
Q1 2022 May 16, 2022	SELL	$30.71 - $45.71 $1.94 Million - $2.89 Million	-63,300 Reduced 54.38%	53,100 $1.76 Million
Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $1.46 Million - $1.85 Million	39,300 Added 50.97%	116,400 $4.95 Million
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $2.88 Million - $4.11 Million	-71,600 Reduced 48.15%	77,100 $3.42 Million
Q2 2021 Aug 11, 2021	BUY	$54.88 - $79.29 $2.79 Million - $4.04 Million	50,900 Added 52.04%	148,700 $8.45 Million
Q1 2021 May 17, 2021	SELL	$70.65 - $96.76 $3.17 Million - $4.34 Million	-44,900 Reduced 31.46%	97,800 $7.32 Million
Q4 2020 Feb 16, 2021	SELL	$58.41 - $89.06 $3.09 Million - $4.71 Million	-52,900 Reduced 27.04%	142,700 $12.3 Million
Q3 2020 Nov 16, 2020	BUY	$41.13 - $62.45 $3.81 Million - $5.78 Million	92,600 Added 89.9%	195,600 $12 Million
Q2 2020 Aug 14, 2020	SELL	$25.95 - $43.15 $189,435 - $314,995	-7,300 Reduced 6.62%	103,000 $4.28 Million
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $11.3 Million - $33.4 Million	-432,200 Reduced 79.67%	110,300 $3.17 Million
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $19.7 Million - $50.7 Million	327,900 Added 152.8%	542,500 $39.2 Million
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $7.49 Million - $10.1 Million	53,400 Added 33.13%	214,600 $30.1 Million
Q2 2019 Aug 14, 2019	SELL	$157.85 - $183.09 $1.28 Million - $1.48 Million	-8,100 Reduced 4.78%	161,200 $29.5 Million
Q1 2019 May 15, 2019	SELL	$89.33 - $163.65 $15.9 Million - $29.2 Million	-178,300 Reduced 51.29%	169,300 $26.9 Million
Q4 2018 Feb 14, 2019	BUY	$81.94 - $139.71 $15.9 Million - $27 Million	193,500 Added 125.57%	347,600 $33.3 Million
Q3 2018 Nov 14, 2018	BUY	$138.11 - $169.04 $580,062 - $709,968	4,200 Added 2.8%	154,100 $21.8 Million
Q2 2018 Aug 14, 2018	SELL	$140.36 - $175.76 $1.4 Million - $1.76 Million	-10,000 Reduced 6.25%	149,900 $23.5 Million
Q1 2018 May 15, 2018	SELL	$152.15 - $192.33 $16.7 Million - $21.1 Million	-109,800 Reduced 40.71%	159,900 $25.8 Million
Q4 2017 Feb 14, 2018	SELL	$60.72 - $167.34 $9.27 Million - $25.6 Million	-152,700 Reduced 36.15%	269,700 $44.4 Million
Q3 2017 Nov 14, 2017	BUY	$61.4 - $88.52 $25.9 Million - $37.4 Million	422,400	422,400 $26.3 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $350M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account